This compound is a fluorinated heterocyclic compound used as a pharmaceutical intermediate. Its structure features a pyrazolopyridine core with nitrile and fluorine substituents, making it relevant for small-molecule drug synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1350653-26-7
2-(5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidine-4,5,6-triamine
Pharmaceutical intermediate for vericiguat
2-(2-Phenyldiazenyl)propanedinitrile
Pharmaceutical intermediate for Riociguat
Fmoc-L-norvaline
Protected amino acid for peptide synthesis
N-((Phenylmethoxy)carbonyl)-L-tyrosine methyl ester
Peptide synthesis protected amino acid
1-[(2-FLUOROPHENYL)METHYL]PYRAZOLO[3,4-B]PYRIDINE-3-CARBONITRILE
research compound
5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride
Pharmaceutical intermediate for vericiguat synthesis
Ethyl 5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylate
pharmaceutical intermediate
1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride
research compound
5-fluoro-1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridine-3-carbonitrile
GPEUANAWZCBBHU-UHFFFAOYSA-N
C1=CC=C(C(=C1)CN2C3=C(C=C(C=N3)F)C(=N2)C#N)F
—